Intended for healthcare professionals


NICE proposes to withdraw Alzheimer's drugs from NHS

BMJ 2005; 330 doi: (Published 03 March 2005) Cite this as: BMJ 2005;330:495

This article has a correction. Please see:

  1. Zosia Kmietowicz
  1. London

    The drugs donepezil, rivastigmine, galantamine, and memantine should no longer be prescribed on the NHS to treat Alzheimer's disease, says new draft guidance from the National Institute for Clinical Excellence (NICE).

    NICE, the NHS prescribing watchdog for England and Wales, has retracted its previous guidance“issued in 2001 and which said that these drugs should be prescribed for Alzheimer's disease—after reviewing the latest evidence on efficacy and cost effectiveness. Patients currently receiving any of the drugs, however, can continue to do so. Memantine will be available only as part of …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription